Post Categories
Boosting Oncology Research with Artificial Intelligence
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine…
![Hand reaching out, digital medical interface graphic](https://www.qps.com/wp-content/uploads/2024/05/Hand-reaching-out-digital-medical-interface-graphic-scaled.jpg)
Boosting Oncology Research with Artificial Intelligence
May 6, 2024
Artificial intelligence (AI) is rapidly transforming the field of oncology, enhancing the precision of cancer diagnostics and accelerating drug development processes. AI and machine…
The Future of Oncology Treatment
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements…
![nurse adjusting infusion bottle with patient and doctor in background](https://www.qps.com/wp-content/uploads/2024/04/nurse-adjusting-infusion-bottle-with-patient-and-doctor-in-background-scaled.jpg)
The Future of Oncology Treatment
May 1, 2024
The future of oncology holds immense promise, thanks to the tireless efforts of medical researchers. From innovative oncology drugs like antibody-drug conjugates to advancements…
Oncology Drug Development: The Current State of Affairs
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in…
![Happy family smiling together, woman wearing scarf on head due to chemo treatment](https://www.qps.com/wp-content/uploads/2024/04/Happy-family-smiling-together-woman-wearing-scarf-on-head-due-to-chemo-treatment-scaled.jpg)
Oncology Drug Development: The Current State of Affairs
April 29, 2024
Death rates for cancer are lower than ever, having declined as much as 33 percent since 1991. This is largely thanks to innovations in…
Hacking the Nervous System to Improve Cancer Treatment
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
![graphic illustration of nervous system](https://www.qps.com/wp-content/uploads/2024/04/graphic-illustration-of-human-nervous-system-scaled.jpg)
Hacking the Nervous System to Improve Cancer Treatment
April 22, 2024
The relationship between cancer and the nervous system has been a curiosity and mystery for nearly two centuries. Jean Cruveilhier’s initial observations in the…
Oncology Drug Development: A Short History
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
![Patient entering CT scan](https://www.qps.com/wp-content/uploads/2024/04/Patient-entering-CT-scan-scaled.jpg)
Oncology Drug Development: A Short History
April 17, 2024
Humans have practiced oncology — the study and treatment of cancer — since long before the invention of the scalpel. The history of oncology…
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
![Overweight senior man sitting outside with cane](https://www.qps.com/wp-content/uploads/2024/04/Overweight-senior-man-sitting-outside-with-cane-scaled.jpg)
New Class of Weight Loss Drugs Shows Promise in Treating Heart Disease
April 15, 2024
NodThera, a biotech company based in Cambridge, England, is developing a new class of medicines that inhibit the NOD-, LRR- and pyrin domain-containing protein…
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
![Close-up of hand holding vaccine vial](https://www.qps.com/wp-content/uploads/2024/04/Close-up-of-hand-holding-vaccine-vial-scaled.jpg)
COVID-19 Wiped Out a Flu Strain, Spurring Revamped Vaccine Strategy
April 8, 2024
Annual flu shots in the United States are going to be made a little differently this year, as one of the flu strains usually…
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
![Digital illustration of human brain with brain waves](https://www.qps.com/wp-content/uploads/2024/03/Digital-illustration-of-human-brain-with-brain-waves-scaled.jpg)
Scientists Harness Brain Waves for Life-Changing Neuroprosthetics
April 3, 2024
Genetic abnormalities, neurodegenerative conditions, and trauma can all impact speech, making it difficult or impossible for those affected to communicate verbally. And while resources…
Vivani Shifts to Weight Management with an Exenatide Implant
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
![Woman looking down at feet on scale](https://www.qps.com/wp-content/uploads/2024/04/Woman-looking-down-at-feet-on-scale-scaled.jpg)
Vivani Shifts to Weight Management with an Exenatide Implant
April 1, 2024
As GLP-1 receptor agonist injections continue to gain acceptance as effective solutions for weight management and cardiovascular health, a tiny drug-delivering implant from Vivani…
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
![CTIS Timeline Infographic](https://www.qps.com/wp-content/uploads/2023/04/Timeline-Infographic_v1_horizontal-V1_RGB-01-scaled.jpg)
EU Clinical Trial Regulation 536/2014 and CTIS: Common Questions and Answers
March 20, 2024
As reported in our previous CTIS-related blog post, the way clinical trials are documented in the European Union (EU) is changing. By January 31,…
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
![Happy young boy in wheelchair with his arms up](https://www.qps.com/wp-content/uploads/2024/03/Happy-young-boy-in-wheelchair-with-his-arms-up-scaled.jpg)
Customized Therapies Offer Hope for Patients with Ultra-Rare Genetic Diseases
March 18, 2024
Leveraging rapid developments in gene therapy, researchers are designing new ways to target ultra-rare genetic diseases with treatments tailored to a patient’s specific genetic…
Navigating Changes to EU Clinical Trial Management: What You Need to Know
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
![European Medicines Agency Flag](https://www.qps.com/wp-content/uploads/2024/03/European-Medicines-Agency-Flag-scaled.jpg)
Navigating Changes to EU Clinical Trial Management: What You Need to Know
March 13, 2024
The face of clinical trials in the European Union (EU) is changing. By January 31, 2025, all ongoing clinical trials must move to the…
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
![Digital illustration of human brain, one section highlighted pink indicating tumor](https://www.qps.com/wp-content/uploads/2024/06/Digital-illustration-of-human-brain-one-section-highlighted-pink-indicating-tumor-scaled.jpg)
CAR-T Cell Therapy Shows Promise in Treating Aggressive Brain Tumors
June 13, 2024
Around 200,000 people die from glioblastoma, the most common and most aggressive type of cancerous brain tumor, each year. With a five-year overall survival…
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
![digital illustration of DNA strand and scissors](https://www.qps.com/wp-content/uploads/2024/06/digital-illustration-of-DNA-strand-with-scissors-scaled.jpg)
The CAR-T Conundrum: Are Cutting-Edge Therapies Causing Cancer?
June 10, 2024
In November 2023, the U.S. Food and Drug Administration (FDA) announced an investigation into chimeric antigen receptor (CAR) T-cell therapies, questioning if these promising…
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
![Needle beneath red no symbol](https://www.qps.com/wp-content/uploads/2024/06/Needle-beneath-red-no-symbol-scaled.jpg)
Weight Loss Rebounding: The Challenges of Stopping Obesity Drugs
June 3, 2024
Semaglutide, under the brand names Wegovy® and Ozempic®, has surged in popularity for its ability to help people lose weight and reduce the risk…
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to…
![hand holding two injection pens](https://www.qps.com/wp-content/uploads/2024/05/hand-holding-two-injection-pens-scaled.jpg)
Novo Nordisk Offers a New Contender in Weight Management — in Pill Form
May 20, 2024
The Danish pharmaceutical company Novo Nordisk has announced promising early results for amycretin, a novel oral weight loss medication. This new drug appears to…
Understanding the Rise in Cancer Rates Among Young Adults
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the…
![Young woman with cancer, smiling and sharing photos with sister](https://www.qps.com/wp-content/uploads/2024/05/Young-woman-with-cancer-smiling-and-sharing-photos-with-sister-scaled.jpg)
Understanding the Rise in Cancer Rates Among Young Adults
May 13, 2024
Recent revelations by celebrities about their cancer diagnoses have cast a spotlight on a worrisome trend: the rise in early-onset cancer rates, or the…
Oncology Clinical Trials: Understanding Industry Challenges
In 2024, roughly 2 million people in the United States will be diagnosed with cancer, per the National Cancer Institute. Given that stark statistic,…
![Doctor talking with patient](https://www.qps.com/wp-content/uploads/2024/04/Doctor-talking-with-patient-scaled.jpg)
Oncology Clinical Trials: Understanding Industry Challenges
May 8, 2024
In 2024, roughly 2 million people in the United States will be diagnosed with cancer, per the National Cancer Institute. Given that stark statistic,…
Introduction As global obesity rates continue to rise, the search for effective treatments is more critical than ever. Obesity is associated with an increased…
Introduction Changes in how clinical trials are managed in the European Union (EU), mandated by the European Union Clinical Trial Regulation 536/2014 (EU CTR),…
Introduction RNA based drugs are a promising new class of therapeutics with tremendous potential for treating a wide range of diseases. There are various…
NEWARK, Delaware, June 26, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new laboratory…
NEWARK, Delaware, June 10, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), is pleased to announce new clinical…
NEWARK, Delaware, May 21, 2024/BUSINESS WIRE/ — QPS Holdings, LLC (QPS), a leading global contract research organization (CRO), continues to expand and align its…